Septic shock in pediatrics: the state-of-the-art

Pedro Celiny Ramos Garcia1, Cristian Tedesco Tonial2, Jefferson Pedro Piva3

  • 1Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Hospital São Lucas, Faculdade de Medicina e Terapia Intensiva Pediátrica, Programa de Pós-Graduação em Pediatria e Saúde Infantil, Porto Alegre, RS, Brazil.

Jornal De Pediatria
|December 18, 2019
PubMed

Insights

Pediatric sepsis management requires prompt identification, fluid resuscitation, and antibiotics. Protocols and technology reduce mortality, but careful fluid management is crucial, especially in resource-limited settings.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Emergency medicine

Background:

  • Sepsis is a leading cause of mortality in children.
  • Varied clinical presentations complicate pediatric sepsis definition.
  • Effective management hinges on timely interventions.

Purpose of the Study:

  • To review the definition, diagnosis, and management of pediatric sepsis and septic shock.
  • To highlight key treatment strategies and considerations for resource-poor settings.

Main Methods:

  • Literature search of MEDLINE and Embase databases.
  • Prioritization of articles published within the last five years.
  • Synthesis of data on sepsis definition, diagnosis, and management.

Main Results:

  • Sepsis treatment involves airway stabilization, oxygenation, ventilation, fluid resuscitation, antibiotics, and cardiovascular support.
  • Vasoactive drugs (epinephrine, norepinephrine) are indicated for refractory shock.
  • Bedside ultrasound aids in post-resuscitation management.
  • Refractory shock requires evaluation for specific conditions like cardiac tamponade or adrenal insufficiency.

Conclusions:

  • Protocols and advanced technologies have decreased pediatric sepsis mortality.
  • Early identification, antibiotics, and judicious fluid administration are vital, particularly in resource-limited environments.
  • Multimodal evaluation and addressing underlying causes are essential for optimal outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
173
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
210
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
699
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
494
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
154